Physician

Beata Styka, M.D.

According to 2025 Medicare claims, Beata Styka, M.D. (NPI: 1275623233) practices geriatric medicine in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is BEATA I STYKA MD SC (NPI: 1619171543; TIN: 260282355) and primary practice location at 60463-1435. Styka is affiliated with the American Choice Healthcare, LLC (ACO ID: D0086), participating under the REACH model.

Styka's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,174 traditional Medicare patients, billed 9,098 HCPCS/CPT codes, and received $510,760 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 18,844 prescription claims across 1,338 beneficiaries totaling $1,296,951 in drug costs, led by Eliquis (Apixaban). DME data shows 742 claims. Open Payments data shows 50 records totaling $1,024. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $284,553 to $510,760. Similarly, Part D prescription costs have risen steadily, from $754,818 to $1,296,951. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $19,256 and ending at $56,230.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	762	5,344	$284,553
2016	841	5,755	$324,847
2017	898	6,453	$353,291
2018	980	7,315	$410,162
2019	1,029	7,796	$408,749
2020	1,180	7,323	$355,513
2021	1,205	7,189	$395,518
2022	1,281	7,411	$409,378
2023	1,272	7,972	$421,517
2024	1,174	9,098	$510,760

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	579	12,227	$754,818
2016	659	13,305	$824,543
2017	799	14,355	$845,084
2018	888	15,436	$979,233
2019	938	15,321	$986,563
2020	1,052	15,895	$1,126,256
2021	1,146	16,443	$1,191,425
2022	1,278	16,867	$1,235,249
2023	1,347	18,772	$1,442,102
2024	1,338	18,844	$1,296,951

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	168	616	$18,112
2016	241	870	$20,890
2017	210	675	$16,997
2018	174	749	$18,691
2019	219	911	$27,005
2020	192	808	$19,924
2021	142	571	$13,464
2022	128	597	$13,273
2023	150	576	$18,597
2024	182	742	$52,043

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	977	977	$139
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	596	1,136	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	940	2,236	$68
G0444	Annual depression screening, 5 to 15 minutes	968	968	$20
36415	Insertion of needle into vein for collection of blood sample	951	2,103	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	300	14,245	$273,460
Ozempic	Semaglutide	136	5,192	$158,180
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	98	4,320	$87,896
Januvia	Sitagliptin Phosphate	52	3,740	$66,497
Xarelto	Rivaroxaban	44	1,980	$36,980

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	18	111	$30,685
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	16	118	$8,197
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	14	14	$3,236
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	84	202	$2,920
E1392	Portable oxygen concentrator, rental	Y	N/R	74	$2,552

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	50	$1,024	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Beata Styka, M.D.?

Tedicare shows public-source Medicare data for Beata Styka, M.D. (NPI 1275623233), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Beata Styka, M.D. have ACO affiliation data?

Beata Styka, M.D. is shown with ACO affiliation data for American Choice Healthcare, LLC (REACH, ACO ID D0086).

What billing organization is linked to Beata Styka, M.D.?

Beata Styka, M.D. is linked to BEATA I STYKA MD SC (billing NPI 1619171543) in the available physician profile data.

Does Beata Styka, M.D. have Open Payments data?

Beata Styka, M.D. has 50 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.